Evidence map›Paper›PMID 33240269›Full record

ArticleFrontiers in immunology2020

Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects.

Isaac Rosado-Sánchez, Rebeca De Pablo-Bernal, Anna Rull, Juan Gónzalez, Santiago Moreno, David Vinuesa, Vicente Estrada, María Ángeles Muñoz-Fernández, Francesc Vidal, Manuel Leal and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Clinical perspectives on the age-related increase of immunosuppressive activity.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  5. Involvement of impaired CD8Reproductive biology and endocrinology : RB&E · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 1 country.

Isaac Rosado-SánchezInstitute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital (HUVR)/Consejo Superior de Investigaciones Científicas (CSIC)/University of Seville, Seville, Spain.
Rebeca De Pablo-BernalInstitute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital (HUVR)/Consejo Superior de Investigaciones Científicas (CSIC)/University of Seville, Seville, Spain.
Anna RullUniversitat Rovira i Virgili, Instituto de Investigación Sanitaria Pere Virgili (IISPV), Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Juan GónzalezUnidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, Spain.
Santiago MorenoServicio de Enfermedades Infecciosas, Hospital Ramón y Cajal, Madrid, Spain.
David VinuesaUnidad de Enfermedades Infecciosas, Hospital Universitario, Universitario San Cecilio, Granada, Spain.
Vicente EstradaHospital Universitario Clínico San Carlos, Madrid, Spain.
María Ángeles Muñoz-FernándezMolecular Immunology Laboratory, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Francesc VidalUniversitat Rovira i Virgili, Instituto de Investigación Sanitaria Pere Virgili (IISPV), Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Manuel LealInstitute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital (HUVR)/Consejo Superior de Investigaciones Científicas (CSIC)/University of Seville, Seville, Spain.
Yolanda María PachecoInstitute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital (HUVR)/Consejo Superior de Investigaciones Científicas (CSIC)/University of Seville, Seville, Spain.
Instituto de Biomedicina de Sevilla · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESConsejo Superior de Investigaciones Científicas · ESHospital Clínico San Carlos · ESHospital San Juan de la Cruz · ESHospital Universitario La Paz · ESHospital Universitario Ramón y Cajal · ESInstitut d'Investigació Sanitària Pere Virgili · ESInstituto de Investigación Biosanitaria de Granada · ESUniversidad Rovira i Virgili · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We have previously observed increased levels of inflammatory biomarkers and Th17 as well as Treg cells, but not other T-cell specific alterations, preceding immunodiscordance of successfully-treated HIV-infected subjects. Our hypothesis is that this could be related with potential alterations in myeloid-derived suppressor cells (MDSCs) and/or monocyte subsets. Methods: We determined the frequencies of MDSCs and monocyte subsets and the expression of several functional markers (CCR2, Results: Increased frequencies of MDSCs, but normal distribution of monocyte subsets, preceded immunodiscordance. The expression of several functional markers, such as CCR2, CD16, CD11b and PDL1, on MDSCs and monocyte subsets was altered in this scenario. MDSC and monocyte-related functional markers were associated with soluble biomarkers and T-cell parameters. Several of these cellular alterations were not restored after 24 months of suppressive cART. Conclusion: An early immunosuppressive environment, characterized by the expansion of MDSCs and Tregs, precedes immunodiscordance and is related with a highly inflammatory status.

Indexed as

AdultAntiretroviral Therapy, Highly ActiveB7-H1 AntigenBiomarkersCD4 Lymphocyte CountCohort StudiesHIV InfectionsHumansImmune ToleranceImmunity, InnateInflammation MediatorsMaleMiddle AgedModels, ImmunologicalMonocytesMyeloid-Derived Suppressor CellsB7-H1 AntigenBiomarkersCCR2 protein, humanCD274 protein, humanInflammation MediatorsReceptors, CCR2CCR2HIVimmunodiscordanceMDSCmonocytesPDL-1Th17Treg

Identifiers

PMID33240269
PMCPMC7677300
OpenAlexW3097095776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.